Cisplatin's potential for type 2 diabetes repositioning by inhibiting CDKN1A, FAS, and SESN1. - Syed Aun Muhammad; Syeda Tahira Qousain Naqvi; Thanh Minh Nguyen 002; Xiaogang Wu; Fahad Munir; Muhammad Babar Jamshed; QiYu Zhang (Comput. Biol. Medicine, 2021)